Income Tax Expense (Benefit) of Quantumzyme Corp. from 31 Oct 2016 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Quantumzyme Corp. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Oct 2016 to 31 Oct 2025.
  • Quantumzyme Corp. Income Tax Expense (Benefit) for the quarter ending 31 Oct 2025 was $0.
  • Quantumzyme Corp. annual Income Tax Expense (Benefit) for 2025 was $0.
  • Quantumzyme Corp. annual Income Tax Expense (Benefit) for 2024 was $0.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)

Quantumzyme Corp. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 $0 01 Aug 2025 31 Oct 2025 10-Q 15 Dec 2025 2026 Q1
Q1 2025 $0 $0 01 Feb 2025 30 Apr 2025 10-Q 20 Jun 2025 2025 Q3
Q3 2024 $0 01 Aug 2024 31 Oct 2024 10-Q 15 Dec 2025 2026 Q1
Q1 2024 $0 01 Feb 2024 30 Apr 2024 10-Q 20 Jun 2025 2025 Q3
Q3 2017 $370 +$4,642 +93% 01 Aug 2017 31 Oct 2017 10-Q 18 Dec 2017 2018 Q1
Q3 2016 $5,012 01 Aug 2016 31 Oct 2016 10-Q 18 Dec 2017 2018 Q1

Quantumzyme Corp. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $0 $0 01 Aug 2024 31 Jul 2025 10-K/A 17 Nov 2025 2025 FY
2024 $0 01 Aug 2023 31 Jul 2024 10-K/A 17 Nov 2025 2025 FY
2017 $5,799 01 Aug 2016 31 Jul 2017 10-K 20 Nov 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.